Sanofi enters M&A bonanza
French drugmaker strengthens rare diseases portfolio with blood disorder purchases
Sanofi has entered the 2018 takeover scene with gusto, snapping up two small biotechs for a combined total of about £11.5 billion, and hinting that another acquisition isn’t out of the question.